Elva Díaz | |
---|---|
Born | |
Occupation(s) | Professor, Department of Pharmacology at UC Davis |
Academic background | |
Education |
|
Alma mater | Stanford University |
Thesis | Molecular analysis of mannose 6-phosphate receptor trafficking (1998) |
Doctoral advisor | Suzanne Pfeffer |
Academic work | |
Discipline | Pharmacologist |
Elva Díaz, director of the pharmacology department at UC Davis,[1] is a researcher who specializes in developmental neurobiology, using rodents to study molecular mechanisms of brain development.[2] Diaz is a recipient of the National Institutes of Health Director's New Innovator Award, as well as the UC Davis ADVANCE Scholar Award.
Early life and education
Elva Denise Díaz[3] was born in San Jose, California; her parents were of Mexican origin.[4]
Díaz attended Harvard University for her undergraduate studies where she majored in Biomechanical Science.[2] She earned a Ph.D. in Biochemistry at Stanford University.[2]
Research and career
Díaz's research focuses on the molecular mechanisms involved in the development, function, and plasticity of excitatory synapses in the central nervous system (CNS).[2]
Díaz received a $40,000 Alfred P. Sloan Research Fellowship in 2004. The purpose of her research was "to better understand the function of certain molecules in the development of brain tumors — particularly in medulloblastomas, the most common form in children — to determine why they develop in the first place".[5]
Díaz was also a 2009 recipient of a $1.5 million NIH Director's New Innovator Award.[6] The purposes of her studies were, "1) to reprogram brain tumor cells toward a more stem-like phenotype, 2) to characterize the tumorigenic potential of such reprogrammed tumor stem-like cell lines, and 3) to identify chemical compounds that specifically target the reprogrammed tumor stem-like cells."[7]
One of Díaz's core areas of research involves the exploration of the potential of pluripotent stem cells combined with immunotherapy to treat brain cancers.[8] Her research has identified that tumor cells in the brain form pseudo synapses with the CNS to take over nutrients and mimic normal cellular communications.[8]
Elva Díaz also investigates the dynamics of AMPA-type glutamate receptors, key components in fast synaptic transmission essential for memory in the brain.[9] Díaz's team has identified a protein called SynDIG4 that regulates this receptor movement, potentially enhancing memory strength.[9]
Díaz is chair of the UC Davis Neuroscience Graduate Program.[10]
Awards
- Helen Hay Whitney Fellowship, 1999[11]
- Alfred P. Sloan Research Fellowship, 2004[11]
- National Institutes of Health Director's New Innovator Award, 2009[7]
- UC Davis ADVANCE Scholar Award, 2023[3]
Selected publications
- Matt, Lucas; Kirk, Lyndsey M; Chenaux, George; Speca, David J; Puhger, Kyle R; Pride, Michael C; Qneibi, Mohammad; Haham, Tomer; Plambeck, Kristopher E; Stern-Bach, Yael; Silverman, Jill L; Crawley, Jacqueline N; Hell, Johannes W; Díaz, Elva (February 27, 2018). "SynDIG4/Prrt1 Is Required for Excitatory Synapse Development and Plasticity Underlying Cognitive Function". Cell Reports. 22 (9): 2246–2253. doi:10.1016/j.celrep.2018.02.026. PMC 5856126. PMID 29490264.
- Chenaux, George; Matt, Lucas; Hill, Travis C; Kaur, Inderpreet; Liu, Xiao-Bo; Kirk, Lyndsey M; Speca, David J; McMahon, Samuel A; Zito, Karen; Hell, Johannes W; Díaz, Elva (October 21, 2016). "Loss of SynDIG1 Reduces Excitatory Synapse Maturation But Not Formation In Vivo". eNeuro. 3 (5). doi:10.1523/ENEURO.0130-16.2016. PMC 5073248. PMID 27800545.
- Kaur, Inderpreet; Yarov-Yarovoy, Vladimir; Kirk, Lyndsey M; Plambeck, Kristopher E; Barragan, Eden V; Ontiveros, Eric S; Díaz, Elva (July 20, 2016). "Activity-Dependent Palmitoylation Controls SynDIG1 Stability, Localization, and Function". Journal of Neuroscience. 36 (29): 7562–7568. doi:10.1523/JNEUROSCI.4859-14.2016. PMC 4951570. PMID 27445135.
- Kirk, Lyndsey M; Ti, Shu W; Bishop, Hannah I; Orozco-Llamas, Mayra; Pham, Michelle; Trimmer, James S; Díaz, Elva (August 1, 2016). "Distribution of the SynDIG4/proline-rich transmembrane protein 1 in rat brain". Journal of Comparative Neurology. 524 (11): 2266–2280. doi:10.1002/cne.23945. PMC 4892943. PMID 26660156.
- Barisone, Gustavo A; Ngo, Tin; Tran, Martin; Cortes, Daniel; Shahi, Mehdi H; Nguyen, Tuong-Vi; Perez-Lanza, Danial; Matayasuwan, Wanna; Díaz, Elva (July 10, 2012). "Role of MXD3 in proliferation of DAOY human medulloblastoma cells". PLOS ONE. 7 (7): e38508. Bibcode:2012PLoSO...738508B. doi:10.1371/journal.pone.0038508. PMC 3393725. PMID 22808009.
- Kalashnikova, Evgenia; Lorca, Ramón A; Kaur, Inderpreet; Barisone, Gustavo A; Li, Bonnie; Ishimaru, Tatsuto; Trimmer, James S; Mohapatra, Durga P; Díaz, Elva (January 14, 2010). "SynDIG1: an activity-regulated, AMPA- receptor-interacting transmembrane protein that regulates excitatory synapse development". Neuron. 65 (1): 80–93. doi:10.1016/j.neuron.2009.12.021. PMC 2822728. PMID 20152115.
- Yun, Jun-Soo; Rust, Jennifer M; Ishimaru, Tatsuto; Díaz, Elva (September 24, 2007). "A novel role of the Mad family member Mad3 in cerebellar granule neuron precursor proliferation". Mol Cell Biol. 27 (23): 8178–8189. doi:10.1128/MCB.00656-06. PMC 2169189. PMID 17893326.
- Dìaz, Elva; Ge, Yongchao; Yang, Yee Hwa; Loh, Kenneth C; Serafini, Tito A.; Okazaki, Yasushi; Hayashizaki, Yoshihide; Speed, Terrence P; Ngai, John; Scheiffele, Peter (October 24, 2002). "Molecular analysis of gene expression in the developing pontocerebellar projection system". Neuron. 36 (3): 417–434. doi:10.1016/s0896-6273(02)01016-4. PMID 12408845.
- Barisone, Gustavo A; Yun, Jun-Soo; Díaz, Elva (February 15, 2008). "From cerebellar proliferation to tumorigenesis: new insights into the role of Mad3". Cell Cycle. 7 (4): 423–427. doi:10.4161/cc.7.4.5413. PMID 18235219 – via 18235219.
- Plambeck, Kristopher E; He, Chun-Wei; Navarro, Hector H; Díaz, Elva (April 8, 2022). "Mutually Dependent Clustering of SynDIG4/PRRT1 and AMPA Receptor Subunits GluA1 and GluA2 in Heterologous Cells and Primary Neurons". Frontiers in Molecular Neuroscience. 15: 788620. doi:10.3389/fnmol.2022.788620. PMC 9024365. PMID 35465096.
References
- ^ "Elva Diaz – The Grass Foundation". Retrieved 2024-04-29.
- ^ a b c d Doval, Calvin Y. (2019-11-07). "Elva Diaz, Ph.D. | Pharmacology and Toxicology". ptx.ucdavis.edu. Retrieved 2024-04-24.
- ^ a b O'Donnell, Thomas (2023-08-11). "Announcing the 2023 ADVANCE Scholar Award Recipients | Diversity, Equity & Inclusion". diversity.ucdavis.edu. Retrieved 2024-06-24.
- ^ "Faculty Mentors, Elva Díaz". Interdisciplinary Research Training Institute (IRTI). Retrieved 2024-04-25.
- ^ Wood, Trina (Fall 2007). "Connections, From Bench to Bedside". UC Davis Magazine. 25 (1). Archived from the original on June 10, 2010. Retrieved September 1, 2024.
- ^ "Governmsnt should invest more in scientific research". The Sacramento Bee. 2013-08-03. pp. A9. Retrieved 2024-09-01.
- ^ a b "2009 Awardees | NIH Common Fund - Elva D. Diaz". commonfund.nih.gov. Retrieved 2024-04-25.
- ^ a b "Episode 21: Elva Diaz, PhD". Conjugate: Illustration and Science Blog. Retrieved 2024-04-24.
- ^ a b Davis, Andy Fell-UC (2018-03-02). "Protein calls up 'reserves' to make stronger memories". Futurity. Retrieved 2024-04-29.
- ^ Cummings, Kimberly Pearce (2021-07-03). "Elva Diaz, Ph.D. | ucdneuro". ucdneuro.sf.ucdavis.edu. Retrieved 2024-09-01.
- ^ a b "Unlocking the Mysteries of the Brain | Benefunder". www.benefunder.com. Retrieved 2024-04-26.
External links
- Harvard University alumni
- Stanford University alumni
- University of California, Davis faculty
- American women scientists
- University of California, Berkeley alumni
- American neuroscientists
- American biochemists
- Scientists from California
- Living people
- NIH Director's New Innovator Award recipients
- Helen Hay Whitney Foundation fellows
- American pharmacologists